Inhibition of Notch1 increases paclitaxel sensitivity to human breast cancer

Background Paclitaxel （PAC） is the first-line chemotherapy drug for most breast cancer patients,but clinical studies showed that some breast cancer patients were insensitive to PAC,which led to chemotherapy failure.It was reported that Notch1 signaling participated in drug resistance of breast cance...

Ausführliche Beschreibung